950210 — Prestige Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Prestige Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	407	235	230	165	132
Net Total Accounts Receivable
Net Total Receivables	—	—	0.101	0.282	0.448
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	407	241	237	180	155
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.7	29.7	236	235	252
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	535	387	565	512	550
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.4	32.3	103	105	122
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	25.8	54	222	196	247
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	509	333	343	316	303
Total Liabilities & Shareholders' Equity	535	387	565	512	550
Total Common Shares Outstanding